<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: blockbuster drug</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Misuse of drug patenting could cost the health system billions</title>
   	 <description>(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.</description>
     <link>http://medicalxpress.com/news/2013-04-misuse-drug-patenting-health-billions.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 10 Apr 2013 09:21:59 EST</pubDate>
	 <guid isPermaLink="false">news284804511</guid>
	 
</item>
<item>
     <title>FDA clears anticlotting drug Eliquis</title>
   	 <description>The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes and heart attacks.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-anticlotting-drug-eliquis.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 28 Dec 2012 17:54:15 EST</pubDate>
	 <guid isPermaLink="false">news275939650</guid>
	 
</item>
<item>
     <title>Trojan horse drug therapy provides new approach to treating breast cancer</title>
   	 <description>When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.</description>
     <link>http://medicalxpress.com/news/2012-10-trojan-horse-drug-therapy-approach.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 02 Oct 2012 00:20:01 EST</pubDate>
	 <guid isPermaLink="false">news268330092</guid>
	 
</item>
<item>
     <title>Plavix's new generic status could be boon for patients</title>
   	 <description>(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable. </description>
     <link>http://medicalxpress.com/news/2012-05-plavix-status-boon-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 15 May 2012 16:20:01 EST</pubDate>
	 <guid isPermaLink="false">news256316529</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/plavixsnewge.jpg" width="90" height="90" />
</item>
<item>
     <title>Merck blood thinner shows mixed results: study</title>
   	 <description> An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.</description>
     <link>http://medicalxpress.com/news/2012-03-merck-blood-thinner-results.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 24 Mar 2012 19:12:54 EST</pubDate>
	 <guid isPermaLink="false">news251835164</guid>
	 
</item>
<item>
     <title>Experts challenge FDA over approval for new dose of Alzheimer's drug</title>
   	 <description>Approval for a new dose of a best-selling Alzheimer's drug &quot;breached the FDA's own regulatory standard&quot; and has led to &quot;incomplete and distorted messages&quot; about the drug, warn experts in the British Medical Journal today.</description>
     <link>http://medicalxpress.com/news/2012-03-experts-fda-dose-alzheimer-drug.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 22 Mar 2012 19:30:01 EST</pubDate>
	 <guid isPermaLink="false">news251654252</guid>
	 
</item>
<item>
     <title>Avastin disappoints against ovarian cancer</title>
   	 <description>Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.</description>
     <link>http://medicalxpress.com/news/2011-12-avastin-disappoints-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 28 Dec 2011 17:43:03 EST</pubDate>
	 <guid isPermaLink="false">news244316573</guid>
	 
</item>
<item>
     <title>Statin-intolerant patients need a different type of clinical trial</title>
   	 <description>(Medical Xpress) -- Millions of people take statins, the blockbuster drug that lowers low-density lipoprotein (LDL), the so-called bad cholesterol. But as many as 20 percent of them develop adverse effects such as muscle fatigue and weakness and impaired cognition. Rockefeller University scientists Patricia Maningat and Jan L. Breslow, writing in this week&amp;#146;s issue of the New England Journal of Medicine, argue that clinical trials need to be designed to address the needs of statin-intolerant patients.</description>
     <link>http://medicalxpress.com/news/2011-11-statin-intolerant-patients-clinical-trial.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 18 Nov 2011 08:01:46 EST</pubDate>
	 <guid isPermaLink="false">news240825665</guid>
	 
</item>
<item>
     <title>FDA backs Vytorin for kidney disease patients</title>
   	 <description>(AP) --  The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.</description>
     <link>http://medicalxpress.com/news/2011-10-fda-vytorin-kidney-disease-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 31 Oct 2011 12:30:12 EST</pubDate>
	 <guid isPermaLink="false">news239283003</guid>
	 
</item>
<item>
     <title>Palliative care's promise, concerns</title>
   	 <description>What if a new medication for severely ill patients had no role in curing them but made them feel much better despite being sick? Let's say this elixir were found to decrease the pain and nausea of cancer patients, improve the sleep and energy of heart failure patients, prolong the lives of people with kidney failure, drive down healthcare expenditures and ease the burdens of caregivers?</description>
     <link>http://medicalxpress.com/news/2011-10-palliative.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 28 Oct 2011 13:35:25 EST</pubDate>
	 <guid isPermaLink="false">news239027714</guid>
	 
</item>
<item>
     <title>FDA approves first generic versions of Zyprexa</title>
   	 <description>(AP) --  Federal health officials on Monday approved the first generic versions of the blockbuster drug Zyprexa, an expensive treatment for schizophrenia and bipolar mood disorder.</description>
     <link>http://medicalxpress.com/news/2011-10-fda-versions-zyprexa.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 24 Oct 2011 16:38:47 EST</pubDate>
	 <guid isPermaLink="false">news238693121</guid>
	 
</item>
<item>
     <title>Cardiac rehabilitation improves heart rate recovery, boosts survival</title>
   	 <description>For the first time, researchers have discovered cardiac rehabilitation can train the heart to quickly return to its normal rate after exercise.</description>
     <link>http://medicalxpress.com/news/2011-09-cardiac-heart-recovery-boosts-survival.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 26 Sep 2011 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news236267611</guid>
	 
</item>
<item>
     <title>Novartis fights patent rejection in Indian court</title>
   	 <description>(AP) --  In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec.</description>
     <link>http://medicalxpress.com/news/2011-09-novartis-patent-indian-court.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 06 Sep 2011 10:22:55 EST</pubDate>
	 <guid isPermaLink="false">news234523359</guid>
	 
</item>


</channel>
</rss>
